The Genetico Center (CGRM, MOEX: GECO) opened a new medical genetic center on the Technopark territory of the Moscow Center for Innovative Technologies in Healthcare - Medtech Moscow.
Construction, equipment and licensing of the medical center was completed at the end of September 2023.
The new medical genetic center with an area of 200 m² has a capacity of 3,000 patients per year. Patients of all ages can receive consultations from leading geneticists here. A personalized approach will allow assessing the genetic characteristics of each patient in order to diagnose or prevent hereditary pathologies. The center's doctors specialize in various areas of medical genetics: reproductive genetics, oncogenetics, cardiogenetics, ophthalmogenetics, genetics of neuromuscular diseases.
Elizaveta Musatova, medical director of Genetico, noted, "The localization of the new medical genetic center on the territory of Medtech will unite the expertise of practicing doctors, researchers and developers in the field of medicine and will accelerate the introduction of the latest genetic technologies into practical healthcare."
Genetico Center is part of the Artgen Biotech group (ex. HSCI, MOEX: ABIO). Resident of Skolkovo, resident of Technopark Medtech. The company works in the field of medical genetics and genetic research, introducing innovative solutions into healthcare practice for the diagnosis, prevention and treatment of genetic and socially significant diseases.
On April 25, 2023, Genetico conducted an IPO on the Moscow Exchange. At the same time, the order book was oversubscribed 2.5 times. The placement became the first IPO on the Russian market this year. The Moscow Exchange included Genetico shares in the list of securities of the high-tech economy sector.